BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.4.6//EN
TZID:America/Phoenix
X-WR-TIMEZONE:America/Phoenix
BEGIN:VEVENT
UID:2037@azbio.org
DTSTART;TZID=America/Phoenix:20261005T173000
DTEND;TZID=America/Phoenix:20261005T193000
DTSTAMP:20261004T225917Z
URL:https://www.azbio.org/events/leading-women-biotech-and-beyond-6
SUMMARY:Leading Women: Biotech and Beyond - 850 PBC - 5 Oct 26 17:30
DESCRIPTION:\nJoin us to kick off Arizona Bioscience Week in style!\nLeadin
 g Women: Biotech and Beyond\n\nJoin us for cocktails connections and stimu
 lating conversation with some of biotech’s leading women.&nbsp\; &nbsp\;
  &nbsp\;\n\nDate:&nbsp\; Monday\, October 5\, 2026\n\nTime:&nbsp\;&nbsp\;5
 :30PM – 7:30 PM\n\nLocation:&nbsp\;850 PBC&nbsp\;\n\n850 N 5th Street\, 
 Phoenix\, Arizona 85004\nAgenda:&nbsp\;&nbsp\;\n5:30 – Cocktails&nbsp\; 
 &amp\; Networking\n\n6:00 – Leading Women Panel&nbsp\;\n\nWelcome: Joan 
 Koerber-Walker &amp\; Scarlett Spring\n\n 	Dr. Karen Anderson\, Arizona St
 ate University\n 	Anne Mazet\, Xcellerant Ventures\n 	Stacey Stevens\, Sim
 BioSys\n 	Scarlett Spring\, Moderator\n\n7:00&nbsp\; – Cocktails &amp\; 
 Networking\n\n7:30&nbsp\; – Event Concludes&nbsp\;\nTickets\nRegistratio
 n is complimentary for AZBio Members\, Elected Leaders\, and credentialed 
 Media.\n\nNon Members:&nbsp\; $50\n\nTo check if your company is an AZBio 
 Member\,&nbsp\;click here.\nSOLD OUT&nbsp\;\nREGISTRATION IS CLOSED\n\nReg
 ister Early - This event fills up fast!\nAbout Our Leading Women\n\n\n&nbs
 p\;\n\nDr. Karen Anderson&nbsp\;\n\n Professor in the School of Life Scien
 ces at Arizona State University\n\nAssociate Dean of Research for the Scho
 ol of Medicine and Advanced Medical Engineering.\n\n&nbsp\;\n\nDr. Karen A
 nderson is a tumor biologist and Professor in the School of Life Sciences 
 at Arizona State University\, where she also serves as the Associate Dean 
 of Research for the School of Medicine and Advanced Medical Engineering. S
 he earned both her M.D. and Ph.D. from Duke University. Dr. Anderson compl
 eted her clinical training in hematology and oncology at Brigham and Women
 ’s Hospital and Dana-Farber Cancer Institute\, and she is board-certifie
 d in both oncology and hematology. Dr. Anderson’s research focuses on ha
 rnessing the immune system to detect and modify cancer development. Her te
 am investigates the diversity and specificity of the adaptive immune respo
 nse. Utilizing molecular techniques such as&nbsp\;nanopore&nbsp\;sequencin
 g\, protein arrays\,&nbsp\;molecular modeling&nbsp\;and functional genomic
 s\, her group explores the early immune alterations associated with cancer
  to identify novel targets for treatment and vaccine development.\n\n\n\n&
 nbsp\;\n\nJoan Koerber-Walker\n\nPresident &amp\; CEO\, Arizona Bioindustr
 y Association\n\nChairman\, Opportunity Through Entrepreneurship Foundatio
 n\n\n&nbsp\;\n\nAs President and CEO of AZBio\, Joan Koerber-Walker works 
 on behalf of the Arizona Bioscience and Medical Technology Industry to sup
 port the growth of the industry\, its members and our community on the loc
 al and national level. Joan is also a life science investor and has served
  on the boards of numerous for-profit and non-profit organizations. Over h
 er career\, she has championed innovation in the halls of government and h
 as worked with innovators on six continents plus points in between.&nbsp\;
  (Joan's not a fan of cold weather and there is not a lot happening on tha
 t seventh continent.)&nbsp\;\n\n\n\n&nbsp\;\n\nAnne Mazet\n\nChief of Staf
 f\n\nJET FUEL\, Xcellerant Ventures &amp\; The Jetstream Venture Fund\n\n&
 nbsp\;\n\nAnne serves as Chief of Staff to Xcellerant Venture’s JET FUEL
  Team. JET FUEL is an elite group of experts who bring hands-on experience
  across technology\, go-to-market strategy\, finance\, and growth directly
  to Xcellerant Ventures and The Jetstream Venture Fund’s founders and po
 rtfolio companies.&nbsp\;A veteran of J.P. Morgan\, CNN\, Spectrum Science
  Communications and Moore Capital Management\, Anne brings deep expertise 
 in organizational development and executive operations. She has a proven t
 rack record of managing high-performing teams and partnering with founders
  and executives to streamline operations and accelerate execution.&nbsp\;A
 nne holds a Bachelor of Science in Communications and Journalism from Itha
 ca College\, and furthered her education at the New York Institute of Fina
 nce\, where she focused on the securities industry and alternative investm
 ents.\n\n\n\n&nbsp\;\n\nStacey Stevens\n\nPresident &amp\; CEO\n\nSimBioSy
 s\n\n&nbsp\;\n\nStacey Stevens is a seasoned healthcare executive and stra
 tegic advisor with over two decades of leadership experience driving innov
 ation in medical technology\, oncology\, and women’s health. She current
 ly serves as President and CEO of SimBioSys\, where she is leading efforts
  to transform cancer care through advanced simulation and precision medici
 ne. Stacey is also the Founding Partner of Ellevate\, a global strategic a
 dvisory firm accelerating the adoption of scientific breakthroughs in wome
 n’s health\, where she has worked with Fortune 100 companies and early-s
 tage AI innovators in maternal health and oncology. In addition\, she advi
 ses Learn Look Locate\, supporting global breast cancer awareness and pati
 ent advocacy initiatives. Previously\, Stacey spent nearly 17 years at iCA
 D\, where she served in multiple executive roles\, including President and
  CEO\, and helped establish the company as a leader in AI-powered cancer d
 etection and therapy solutions. Earlier in her career\, she held senior le
 adership positions at Philips Healthcare and Hewlett-Packard\, spearheadin
 g global marketing and strategy initiatives across cardiac care and ultras
 ound.\n\n\n\n&nbsp\;\n\nScarlett Spring\n\n&nbsp\;\n\n&nbsp\;\n\nScarlett 
 Spring’s career began in big pharma\, where she worked for 20 years for 
 companies like Merck and AstraZeneca\, helping to launch notable drugs suc
 h as Prilosec\, Nexium\, and Crestor. She later led AstraZeneca’s oncolo
 gy portfolio\, introducing treatments for lung\, breast\, and prostate can
 cers. After moving to Phoenix\, she spent time at the Greater Phoenix Econ
 omic Council (GPEC)\, gaining experience in economic development\, before 
 returning to the entrepreneurial space leading a company focused on lung c
 ancer diagnostics.&nbsp\;\n\n&nbsp\;\nSponsorships are available.&nbsp\;\n
 \n\nFor more information\,&nbsp\;contact AZBio.\nThank You Sponsors!\n&nbs
 p\; \n\n&nbsp\;\n\n
CATEGORIES:AZ - Central
LOCATION:850 PBC\, 850 N 5th Street\, Phoenix\, AZ\, 85004\, United States
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=850 N 5th Street\, Phoenix\
 , AZ\, 85004\, United States;X-APPLE-RADIUS=100;X-TITLE=850 PBC:geo:0,0
END:VEVENT
BEGIN:VTIMEZONE
TZID:America/Phoenix
X-LIC-LOCATION:America/Phoenix
BEGIN:STANDARD
DTSTART:20251005T173000
TZOFFSETFROM:-0700
TZOFFSETTO:-0700
TZNAME:MST
END:STANDARD
END:VTIMEZONE
END:VCALENDAR